Tickerplace logo

Tickerplace

Intellia Therapeutics, Inc. logo

NTLAIntellia Therapeutics, Inc.

NTLA Stock Price, Valuation & Chart | Intellia Therapeutics, Inc.

Compare
$11.210+0.05 (+0.45%)

At close · 23 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

NTLA Historical price chart

NTLA Key Stats

Market Capitalization1.57B
PE Ratio-3.34
EPS-3.36
Trading Volume3.56M
Today's High/Low11.24/10.58
Dividend Yield0.00
52 Week High/Low26.35/7.95
Shares Outstanding140.13M
NTLA Financial Statement
NTLA Analyst ratings
NTLA Analysis & performance metrics

NTLA Company profile

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1…

NTLA Management team

Management
James E. Basta Esq., J.D.
Executive Vice President, General Counsel & Corporate Secretary
Edward J. Dulac IIICFO
Executive Vice President, Chief Financial Officer and Treasurer
Michael P. Dube
Vice President, CAO & Principal Accounting Officer
Laura Sepp-Lorenzino Ph.D.CEO
Special Advisor to the Chief Executive Officer
Rachel E. Haurwitz Ph.D.
Co-Founder
Andrew May Ph.D.
Founder and Member of Scientific Advisor Board
Derrick J. Rossi Ph.D.
Founder & Member of Scientific Advisor Board
John M. Leonard M.D.CEO
President, Chief Executive Officer & Director
Total 8 executives

NTLA Frequently asked questions

What is Intellia Therapeutics, Inc. (NTLA) Stock Price?

Current stock price of Intellia Therapeutics, Inc. (NTLA) stock is $11.210. The stock price is +0.45% higher in the session. The intraday range can be seen from this page. Volume of Intellia Therapeutics, Inc. (NTLA) stock is 3.56M.

Last updated at 23 Oct 2026, 08:00 pm.

Why is the Intellia Therapeutics, Inc. (NTLA) stock price going up or down today?

The stock price of Intellia Therapeutics, Inc. (NTLA) can change with earnings, company news, and overall market sentiment. Intellia Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Intellia Therapeutics, Inc. stock expensive at its current price?

Whether Intellia Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NTLA on this page is -3.34. EPS on this page is -3.36. Compare those figures with peers and growth expectations before deciding if the current Intellia Therapeutics, Inc. price is justified.

How has the stock price of Intellia Therapeutics, Inc. (NTLA) performed historically?

Historical performance for Intellia Therapeutics, Inc. (NTLA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NTLA reacted to past earnings and market events.

Should I buy Intellia Therapeutics, Inc. (NTLA) stock, at this price?

Buying Intellia Therapeutics, Inc. (NTLA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.